Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S D Allen

Showing results (111-120 of 149) with videos related to

Pageof 15
Sort By:
Diagnostic Microbiology and Infectious Disease|March 1, 1995
Comparative antimicrobial activity of piperacillin-tazobactam tested against more than 5000 recent clinical isolates from five medical centers. A reevaluation after five yearsS A Marshall, K E Aldridge, S D Allen, et al.
Annals of the New York Academy of Sciences|January 1, 1988
Novel 5-phenyl(or phenoxyalkyl)-3-(2-furanyl)-3-(1H-imidazol-1-ylmethyl)-2- methylisoxazolidines. In vitro antifungal activityG A Bennett, G B Mullen, J T Mitchell, et al.
Annals of the New York Academy of Sciences|January 1, 1988
In vitro activity of novel 5-carbonyl derivatives of 3-phenyl-3-(1H-imidazol-1-ylmethyl)- 2-methyl-isoxazolidinesG A Bennett, G B Mullen, T R DeCory, et al.
Annals of Internal Medicine|May 1, 1981
Rapid radioimmunoassay diagnosis of Legionnaires' disease: detection and partial characterization of urinary antigenR B Kohler, S E Zimmerman, E Wilson, et al.
Journal of Clinical Microbiology|January 5, 2000
Typing of Histoplasma capsulatum isolates based on nucleotide sequence variation in the internal transcribed spacer regions of rRNA genesB Jiang, M S Bartlett, S D Allen, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|August 1, 1996
Methods of measuring susceptibility of anaerobic bacteria to trovafloxacin, including quality control parametersA L Barry, P C Fuchs, C Thornsberry, et al.
Diagnostic Microbiology and Infectious Disease|May 1, 1997
Reproducibility of broth microdilution and disk diffusion susceptibility tests of nine antimicrobial agents against Streptococcus pneumoniae ATCC 49619P C Fuchs, A L Barry, S D Brown, et al.
Archives of Internal Medicine|October 1, 1986
Diabetic foot infections. Bacteriologic analysisL J Wheat, S D Allen, M Henry, et al.
Journal of Clinical Microbiology|November 1, 1992
Interpretive criteria and quality control parameters for testing susceptibility of Haemophilus influenzae to enoxacin, ofloxacin, and temafloxacinA L Barry, J H Jorgensen, D J Hardy, et al.
Diagnostic Microbiology and Infectious Disease|January 1, 1988
Effect of clavulanic acid on the susceptibility of clinical anaerobic bacteria to ticarcillin: a multicenter studyP C Fuchs, R N Jones, A L Barry, et al.
Pageof 15

Showing results (111-120 of 149) with videos related to

Sort By:
Pageof 15
Diagnostic Microbiology and Infectious Disease|March 1, 1995
Comparative antimicrobial activity of piperacillin-tazobactam tested against more than 5000 recent clinical isolates from five medical centers. A reevaluation after five yearsS A Marshall, K E Aldridge, S D Allen, et al.
Annals of the New York Academy of Sciences|January 1, 1988
Novel 5-phenyl(or phenoxyalkyl)-3-(2-furanyl)-3-(1H-imidazol-1-ylmethyl)-2- methylisoxazolidines. In vitro antifungal activityG A Bennett, G B Mullen, J T Mitchell, et al.
Annals of the New York Academy of Sciences|January 1, 1988
In vitro activity of novel 5-carbonyl derivatives of 3-phenyl-3-(1H-imidazol-1-ylmethyl)- 2-methyl-isoxazolidinesG A Bennett, G B Mullen, T R DeCory, et al.
Annals of Internal Medicine|May 1, 1981
Rapid radioimmunoassay diagnosis of Legionnaires' disease: detection and partial characterization of urinary antigenR B Kohler, S E Zimmerman, E Wilson, et al.
Journal of Clinical Microbiology|January 5, 2000
Typing of Histoplasma capsulatum isolates based on nucleotide sequence variation in the internal transcribed spacer regions of rRNA genesB Jiang, M S Bartlett, S D Allen, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|August 1, 1996
Methods of measuring susceptibility of anaerobic bacteria to trovafloxacin, including quality control parametersA L Barry, P C Fuchs, C Thornsberry, et al.
Diagnostic Microbiology and Infectious Disease|May 1, 1997
Reproducibility of broth microdilution and disk diffusion susceptibility tests of nine antimicrobial agents against Streptococcus pneumoniae ATCC 49619P C Fuchs, A L Barry, S D Brown, et al.
Archives of Internal Medicine|October 1, 1986
Diabetic foot infections. Bacteriologic analysisL J Wheat, S D Allen, M Henry, et al.
Journal of Clinical Microbiology|November 1, 1992
Interpretive criteria and quality control parameters for testing susceptibility of Haemophilus influenzae to enoxacin, ofloxacin, and temafloxacinA L Barry, J H Jorgensen, D J Hardy, et al.
Diagnostic Microbiology and Infectious Disease|January 1, 1988
Effect of clavulanic acid on the susceptibility of clinical anaerobic bacteria to ticarcillin: a multicenter studyP C Fuchs, R N Jones, A L Barry, et al.
Pageof 15